Court decision may bring an end to CRISPR patent fight

Patents held by the MIT-Harvard Broad Institute for the use of the gene-editing tool CRISPR-Cas9 have been upheld by a federal appeals court, potentially bringing to an end a battle between the institute and the University of California, Berkeley.